Precision Medicine Pillar No. 3: Clinical Discovery. Researchers are taking vast amounts of patient data, often collected through first-ever clinical studies, and putting it into tools like MS Bioscreen that have a direct impact on patient care.
November 15, 2013
October 14, 2013
Through support from the Catalyst Awards, UCSF researcher Aditi Bhargava is working to develop a method for delivering small-molecules to a specific target group of cells for treatment of pain.
September 19, 2013
UCSF neuroscientist Jonah R. Chan, PhD, has been named the winner of the inaugural Barancik Prize for Innovation in MS Research.
July 03, 2013
UCSF scientists discussed their work in developing software, apps and online tools to help veterans with PTSD and brain injuries at the annual "Brain at War" symposium.
May 16, 2013
UC San Francisco has launched a new app for the Apple iPad that presents a novel approach to learning the neurological physical exam, a challenging series of assessments aimed at diagnosing neurological disorders in patients.
May 08, 2013
A new application of an existing medical imaging technology could help predict long-term damage in patients with traumatic brain injury, according to a recent UCSF study.
April 05, 2013
UCSF neurologist Stephen Hauser has been named the winner of its 2013 Charcot award, the top international prize for lifetime achievement in multiple sclerosis research.
April 02, 2013
President Barack Obama has unveiled a bold public-private initiative to map the brain to gain greater insight on how we think, learn and remember and to better understand and treat diseases ranging from autism to schizophrenia.
February 19, 2013
A study by researchers at the Ernest Gallo Clinic and Research Center at UCSF identified a potential new approach for reducing problem drinking: a new family of drugs with the ability to manipulate DNA structure without changing it.
October 19, 2012
As part of receiving the Academic Senate's 12th Annual Faculty Research Lectureship in Clinical Science, behavioral neurologist Bruce Miller, MD, recently gave a lecture in which he described recent advances in frontotemporal dementia (FTD) research.